Skip to main content
Premium Trial:

Request an Annual Quote

Michael Stapleton, Vivien Bonazzi, Tom Schwei, PanVera

Premium

Invitrogen has named Michael Stapleton general manager and vice president of its bioinformatics business and Vivien Bonazzi director of R&D for bioinformatics. Both positions “exemplify Invitrogen’s commitment to making bioinformatics an integral part of its solution set for life science research,” the company said in a statement. Stapleton most recently served as executive vice president and chief operating officer of Accelrys. Bonazzi was director of product development and scientific management at Celera Genomics before joining Invitrogen.


DNAStar has hired Tom Schwei as vice president and general manager. Schwei has held management positions at

Promega

, PanVera, and Invitrogen.

 

Filed under

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.